ASHLYN MARTIN: Open Payments
NPI 1104607217 · SHELBYVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$510 in 23 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $43 · 2025 $510
Food & beverage: $510
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $178 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Vanda Pharmaceuticals Inc. | 2 | $67 |
| Lilly USA, LLC | 3 | $62 |
| Lundbeck LLC | 2 | $37 |
| Novo Nordisk Inc | 2 | $35 |
| Exact Sciences Corporation | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: VRAYLAR, REXULTI, MOUNJARO, FANAPT, HETLIOZ, UBRELVY, JARDIANCE, Wegovy.
Industry payments across KY — which companies pay providers there.
